These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 14458289)

  • 1. On the effect of alimentary lipemia and a natural heparinoid on the fibrinolytic system of man.
    KONTTINEN Y
    Scand J Clin Lab Invest; 1962; 14():87-99. PubMed ID: 14458289
    [No Abstract]   [Full Text] [Related]  

  • 2. [Activation of fibrinolysis and thrombolysis by polysaccharide sulfuric acid esters (heparin, heparinoid)].
    HALSE T
    Arzneimittelforschung; 1962 Jun; 12():574-82. PubMed ID: 13904008
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the modifications of euglobulin fibrinolysis induced after the administration of a synthetic heparinoid].
    CAMERADA P; CONGIU M; LEO P
    Boll Soc Ital Biol Sper; 1959 Nov; 35():1500-2. PubMed ID: 13807123
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect exercised by a heparinoid on hyperlipemia induced in the rabbit by a surface-active agent].
    BINET L; MARQUIS M; QUIVY D
    C R Hebd Seances Acad Sci; 1959 Dec; 249():2693-7. PubMed ID: 13800760
    [No Abstract]   [Full Text] [Related]  

  • 5. THE EFFECT OF HEPARIN PRETREATMENT ON DEVELOPMENT AND CLEARING OF ALIMENTARY LIPEMIA.
    Barboriak JJ; Kory RC; Chamilton LH
    Am J Clin Nutr; 1965 May; 16():412-6. PubMed ID: 14286798
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical and hematochemical observations on the geriatric and gerioprophylactic applications of a heparinoid agent associated with hormovitaminic factors and iodine].
    BENEDETTI G; MAZZA F; FERRETTI GF
    Minerva Med; 1961 Sep; 52():3347-51. PubMed ID: 13867125
    [No Abstract]   [Full Text] [Related]  

  • 7. [USE OF A SYNTHETIC HEPARINOID IN LIPID METABOLISM DISORDERS. PRELIMINARY STUDY].
    RABY C; SAINT-BLANCARD J; PAGE G; BIED B; VIGNE J; OUGIER J
    Sem Ther; 1963 Dec; 39():658-64. PubMed ID: 14116089
    [No Abstract]   [Full Text] [Related]  

  • 8. [RESEARCH ON THE FIBRINOLYTIC AND ANTICOAGULANT ACTION OF A SULFURATED DERIVATIVE OF XYLAN (SYNTHETIC HEPARINOID) WITH A LOW-GRADE POLYMERIZATION].
    CIPOLLI PL; GIBELLI A
    Riv Patol Clin; 1963 Aug; 18():395-403. PubMed ID: 14083551
    [No Abstract]   [Full Text] [Related]  

  • 9. [Modification of the lipoid fractions in alimentary lipemia by administration of heparin with special reference to unsaturated fatty acids. IV].
    KRAUTWALD A; LINKE H; WEIGEL W
    Acta Biol Med Ger; 1959; 3():114-23. PubMed ID: 14411820
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative study of the clarifying activity in vitro of serum after the addition of various heparinoid substances].
    WOLFF R; BRIGNON JJ
    Arch Int Pharmacodyn Ther; 1959 Sep; 121():255-67. PubMed ID: 13845713
    [No Abstract]   [Full Text] [Related]  

  • 11. [ACTION OF THE HEPARINOID, CB-8061, IN MAN. I. APPEARANCE OF PLASMA CLEARING CAPACITY AFTER INJECTION OF A SINGLE DOSE OF THE PRODUCT].
    DUREUX JB; BRIGNON JJ; MARCHAL C
    Therapie; 1964; 19():879-89. PubMed ID: 14190943
    [No Abstract]   [Full Text] [Related]  

  • 12. [Study of the effect of heparin on alimentary lipemia in women in advanced menopause].
    COTTAFAVI M
    Minerva Ginecol; 1955 Dec; 7(23):826-32. PubMed ID: 13288017
    [No Abstract]   [Full Text] [Related]  

  • 13. [RESEARCH ON THE MECHANISM OF ACTION OF A NATURAL HEPARINOID. STUDY OF COAGULATION, FIBRINOLYSIS AND OF THE INTENSITY OF HEMORRHAGE].
    TURAZZA G; GIBELLI A; BISIANI M
    Gazz Int Med Chir; 1963 Dec; 67():2515-26. PubMed ID: 14164429
    [No Abstract]   [Full Text] [Related]  

  • 14. [Post-heparin activity of esterases in human serum. III. Activity following various doses of heparin and effect of alimentary lipemia].
    PAV J; KUHN E; PLACER Z
    Cas Lek Cesk; 1959 Oct; 98():1324-7. PubMed ID: 14431066
    [No Abstract]   [Full Text] [Related]  

  • 15. [STUDIES ON THE CLEARANCE INDUCING EFFECTS OF A NATURAL HEPARINOID].
    WAGENER H; KRUSZEWSKA B; SCHULZ U
    Arzneimittelforschung; 1964 Aug; 14():879-83. PubMed ID: 14344130
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experimental analysis of the interactions between heparin and a duodenal heparinoid].
    Marmo E; Lampa E; Vacca C; Rossi F; Spadaro R; Sannino A
    Arch Sci Med (Torino); 1975; 132(3):83-115. PubMed ID: 56927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [On clinical trials with Heparinoid Sp 54 in lipemia].
    HIGASHINO S; MIYAMOTO T; SAWA C; ISHIMARU Y; KAWASHIMA Y; SUDA M
    Chiryo; 1963 Jul; 45():1279-85. PubMed ID: 13954395
    [No Abstract]   [Full Text] [Related]  

  • 18. [STUDY OF COAGULATION, FIBRINOLYSIS, LIPEMIA AND OPTIC DENSITY IN HYPERCHOLESTERINEMIC RABBITS TREATED WITH NIALAMIDE FOR 2 MONTHS].
    GIBELLI A; DELFAVERO A
    G Gerontol; 1964 Sep; 12():1071-9. PubMed ID: 14258415
    [No Abstract]   [Full Text] [Related]  

  • 19. [On oral treatment with heparin and heparinoids].
    HEYMANN W
    Bibl Haematol; 1963; 15():132-9. PubMed ID: 13954327
    [No Abstract]   [Full Text] [Related]  

  • 20. [ENDOGENOUS FIBRINOLYTIC POTENTIAL AND ITS STIMULATION BY A POLYSACCHARIDE ESTER].
    HALSE D
    Hemostase; 1963; 3():149-64. PubMed ID: 14050812
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.